Neo-Angin Benzydamin (Benzydamine Hydrochloride)

Benzydamine hydrochloride acts by inhibiting pro‑inflammatory cytokines, stabilising cell membranes in the oral mucosa and providing a local anesthetic effect. This combination reduces inflammation, pain and microbial growth at the site of application.

The dosage and frequency are determined by the prescribing healthcare professional based on the patient’s age, condition severity and response to therapy. Patients should follow the prescriber’s instructions and the product label.

Safety data for benzydamine hydrochloride in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and under medical supervision.

Enquiries can be submitted on the product page at gnhindia.com by specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and import documentation.

Unlike systemic oral NSAIDs, benzydamine is applied locally, providing targeted anti‑inflammatory and analgesic effects with minimal systemic exposure. This can result in fewer systemic side effects compared with oral ibuprofen or diclofenac, though direct comparisons depend on the specific clinical scenario.

Store the product at ambient temperature, below 25 °C. Keep it in the original container, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain product stability.

The preparation is applied directly to the affected oral or throat area, typically as a spray or lozenge, according to the prescriber’s directions. Patients should avoid eating or drinking for a short period after application to allow optimal contact.

Serious adverse reactions, although rare, include allergic responses such as angioedema, anaphylaxis, severe mucosal ulceration and, in extremely rare cases, Stevens‑Johnson syndrome. Any signs of severe hypersensitivity require immediate medical attention.

Individuals with known hypersensitivity to benzydamine hydrochloride or any excipients in the formulation should avoid use. Children under six years of age should not use the product without medical advice, and pregnant or breastfeeding women should consult a healthcare professional before use.